Feature | Coronavirus (COVID-19) | August 03, 2020 | By Melinda Taschetta-Millane

Imaging Volumes Hold Steady Post COVID-19 Closures

This data represents wave 4 of a QuickPoLL survey conducted in partnership with an imagePRO panel of radiology professionals created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, according to new QuickPoLL survey results that gauge how radiologists feel about current business and the impact of COVID-19.

Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, according to new QuickPoLL survey results that gauge how radiologists feel about current business and the impact of COVID-19. The data compares results from the third wave, June 1-15, to the fourth wave, June 16-30.

Responses were tallied from approximately 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of the COVID-19 pandemic on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries. Participants were selected as a representative cross-section of the imaging industry. The panel was asked nine questions about their current business to gauge the imaging impact by COVID-19, and the work that lies on the road ahead.

Imaging Volumes Remain Constant

Magnetic resonance imaging (MRI), computed tomography (CT) and portable X-ray study volumes have improved from the first two waves in May, but remain constant compared to wave 3. Outpatient/elective radiology (eg: scheduled studies) and inpatient radiology (eg: ER, bedside and ICU) also remained flat, as did screening radiology (eg: mammography). For a complete comparison of screening volume change for this period, see Table 1.

 

Table 1: This table shows the study volume change for the time period Jun 16-30, 2020, as compared to the same time period in 2019.

 

Imaging Services Surge Slows

Survey participants continue to process a surge of outpatient imaging procedures — 45 percent currently experiencing these surges — due to the COVID-19 pandemic, according to the QuickPoLL results. TMTG defined “surge” as a much larger volume of studies per day than what was experienced before COVID-19. Thirty-four percent don’t believe there will be a surge due to a slow recovery. See Table 2.

 

Table 2: This table shows wave 4 survey results of when survey respondents expect to see a surge in imaging services.

 

Extended hours of operations and increasing workflow efficiency remain the primary methods to manage the surge. When asked if a surge of outpatient imaging procedures materializes, what would be the primary method to manage/address the surge, 41 percent of respondents said they would extend hours of operation. Thirty-three percent would create a more efficient workflow; 3 percent would hire more staff; and 18 percent would do nothing, believing that there will be no surge of outpatient imaging procedures. These results have been the norm since the beginning of this survey in May. See Table 3.

 

Table 3: Wave 4 survey results on how respondents plan to manage and address the surge in imaging services.

 

Poll participants were also asked about the current imaging capacity, defined as percentage of use of imaging modalities during business hours, at their outpatient diagnostic imaging centers (DIC). Eighty to 99 percent of respondents reported that imaging capacity utilization is currently at 28 percent, mirroring the results of wave 3. See Table 4.

 

Table 4: Responses for wave 4 on current imaging capacity at outpatient diagnostic imaging centers.

 

COVID-19’s Grip

according to a special report from the Radiological Society of North America (RSNA) COVID-19 Task Force, published today in the journal Radiology, examination volumes in radiology practices have decreased by 40%-90%. This survey’s numbers indicate that the trend is moving toward the surge happening now versus never happening. Facilities continue to extend hours of operation and create a more efficient workflow to manage this increase of volume.

You can find more information on The MarkeTech Group and services offered at www.themarketechgroup.com/en/solutions/imagepro-products.

Related COVID-19 Survey Content:

Imaging Volumes Continue to Improve Post COVID-19 Closures

Insight on the Impact of COVID-19 on Medical Imaging

The Continued Impact of COVID-19 on the Imaging Industry

Related Coronavirus Content:

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

Cardiac Imaging Best Practices During the COVID-19 Pandemic

RSNA Publishes COVID-19 Best Practices for Radiology Departments

ASE Guidelines for the Protection of Echocardiography Providers During the COVID-19 Outbreak
New CT Scoring Criteria for Timely Diagnosis, Treatment of Coronavirus Disease

FDA Issues New Policy for Imaging Systems During COVID-19

VIDEO: COVID-19 Precautions for Cardiac Imaging —  Interview with Stephen Bloom, M.D.

A Review of Studies Cautions Against Chest CT for Coronavirus Diagnosis

New Research Finds Chest X-ray Not Reliable Diagnostic Tool for COVID-19

VIDEO: Radiology Industry Responding to COVID-19

University of Washington Issues Radiology Policies for COVID-19

VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic — Interview with Hicham Skali, M.D.

New Research Highlights Blood Clot Dangers of COVID-19

Survey Reveals Most Medical Practices are Now Using Telehealth Due to COVID-19

CMS Offers Recommendations on Reopening Healthcare in Areas of Low COVID-19 Cases

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Radiologists Describe Coronavirus CT Imaging Features

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

ACC COVID-19 recommendations for the cardiovascular care team

VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

The Cardiac Implications of Novel Coronavirus

Related Content

RADLogics AI-Powered solution in use: chest X-ray of COVID-19 positive case with heatmap key image.

RADLogics AI-Powered solution in use: chest X-ray of COVID-19 positive case with heatmap key image.

News | Artificial Intelligence | September 23, 2020
September 23, 2020 — RADLogics
The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray.

The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray. Image courtesy of Kundu et al. (2020) PNAS

News | Artificial Intelligence | September 22, 2020
September 22, 2020 — Researchers at the University of Pitts...
New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.

Canon Medical Systems

News | Cardiac Imaging | September 22, 2020
September 22, 2020 — New research from King's College London has
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
According to Philips, MR-STAT is a major shift in MRI, relying on a new, smart acquisition scheme and machine-assisted reconstruction. It delivers multiple quantitative MR parameters in a single fast scan, and represents a significant advance in MR tissue classification, fueling big data algorithms and AI-enabled integrated diagnostic solutions.

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 21, 2020 | By Melinda Taschetta-Millane
A new report,...
Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer. Contrast-enhanced CT (A), PET (B), and fused 18F-FDG PET/CT (C) images are displayed in comparison with contrast-enhanced T1-weighted MRI (D), PET, and fused 18F-FDG PET/MRI (F) images. In CT (A), hyperdense, subcentimeter liver lesion (arrows) in segment VII is suggestive of transient hepatic attenuation difference or small hemangioma. As malignancy cannot be excluded, it needs further investigation. On PET/MRI, lesion is clearly classified as metastasis because of contrast enhancement and tracer uptake due to later acquisition time point. Follow-up CT confirmed diagnosis after 78 d. Images created by Ole Martin, University Dusseldorf, Medical Faculty and Benedikt Schaarschmidt, University Hospital Essen.

News | PET-MRI | September 18, 2020
September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated